Combined Vitamin C and Vitamin E Deficiency Worsens Early Atherosclerosis in Apolipoprotein E–Deficient Mice
OBJECTIVE—To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative stress), 4 combinations of vitamin supplementation (low C/low E, low C/high E, high C/low E, and high C/high E) were studied in ath...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 30; no. 9; pp. 1751 - 1757 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Heart Association, Inc
01.09.2010
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVE—To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative stress), 4 combinations of vitamin supplementation (low C/low E, low C/high E, high C/low E, and high C/high E) were studied in atherosclerosis-prone apolipoprotein E–deficient mice also unable to synthesize their own vitamin C (gulonolactone oxidase); and to evaluate the effect of a more severe depletion of vitamin C alone in a second experiment using gulonolactone oxidase mice carrying the hemizygous deletion of SVCT2 (the vitamin C transporter).
METHODS AND RESULTS—After 8 weeks of a high-fat diet (16% lard and 0.2% cholesterol), atherosclerosis developed in the aortic sinus areas of mice in all diet groups. Each vitamin-deficient diet significantly decreased liver and brain contents of the corresponding vitamin. Combined deficiency of both vitamins increased lipid peroxidation, doubled plaque size, and increased plaque macrophage content by 2- to 3-fold in male mice, although only plaque macrophage content was increased in female mice. A more severe deficiency of vitamin C in gulonolactone oxidase mice with defective cellular uptake of vitamin C increased both oxidative stress and atherosclerosis in apolipoprotein E mice compared with littermates receiving a diet replete in vitamin C, again most clearly in males.
CONCLUSION—Combined deficiencies of vitamins E and C are required to worsen early atherosclerosis in an apolipoprotein E–deficient mouse model. However, a more severe cellular deficiency of vitamin C alone promotes atherosclerosis when vitamin E is replete. |
---|---|
AbstractList | OBJECTIVETo assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative stress), 4 combinations of vitamin supplementation (low C/low E, low C/high E, high C/low E, and high C/high E) were studied in atherosclerosis-prone apolipoprotein E-deficient mice also unable to synthesize their own vitamin C (gulonolactone oxidase(-/-)); and to evaluate the effect of a more severe depletion of vitamin C alone in a second experiment using gulonolactone oxidase(-/-) mice carrying the hemizygous deletion of SVCT2 (the vitamin C transporter).METHODS AND RESULTSAfter 8 weeks of a high-fat diet (16% lard and 0.2% cholesterol), atherosclerosis developed in the aortic sinus areas of mice in all diet groups. Each vitamin-deficient diet significantly decreased liver and brain contents of the corresponding vitamin. Combined deficiency of both vitamins increased lipid peroxidation, doubled plaque size, and increased plaque macrophage content by 2- to 3-fold in male mice, although only plaque macrophage content was increased in female mice. A more severe deficiency of vitamin C in gulonolactone oxidase(-/-) mice with defective cellular uptake of vitamin C increased both oxidative stress and atherosclerosis in apolipoprotein E(-/-) mice compared with littermates receiving a diet replete in vitamin C, again most clearly in males.CONCLUSIONSCombined deficiencies of vitamins E and C are required to worsen early atherosclerosis in an apolipoprotein E-deficient mouse model. However, a more severe cellular deficiency of vitamin C alone promotes atherosclerosis when vitamin E is replete. Objective— To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative stress), 4 combinations of vitamin supplementation (low C/low E, low C/high E, high C/low E, and high C/high E) were studied in atherosclerosis-prone apolipoprotein E–deficient mice also unable to synthesize their own vitamin C (gulonolactone oxidase −/− ); and to evaluate the effect of a more severe depletion of vitamin C alone in a second experiment using gulonolactone oxidase −/− mice carrying the hemizygous deletion of SVCT2 (the vitamin C transporter). Methods and Results— After 8 weeks of a high-fat diet (16% lard and 0.2% cholesterol), atherosclerosis developed in the aortic sinus areas of mice in all diet groups. Each vitamin-deficient diet significantly decreased liver and brain contents of the corresponding vitamin. Combined deficiency of both vitamins increased lipid peroxidation, doubled plaque size, and increased plaque macrophage content by 2- to 3-fold in male mice, although only plaque macrophage content was increased in female mice. A more severe deficiency of vitamin C in gulonolactone oxidase −/− mice with defective cellular uptake of vitamin C increased both oxidative stress and atherosclerosis in apolipoprotein E −/− mice compared with littermates receiving a diet replete in vitamin C, again most clearly in males. Conclusion— Combined deficiencies of vitamins E and C are required to worsen early atherosclerosis in an apolipoprotein E–deficient mouse model. However, a more severe cellular deficiency of vitamin C alone promotes atherosclerosis when vitamin E is replete. OBJECTIVE—To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative stress), 4 combinations of vitamin supplementation (low C/low E, low C/high E, high C/low E, and high C/high E) were studied in atherosclerosis-prone apolipoprotein E–deficient mice also unable to synthesize their own vitamin C (gulonolactone oxidase); and to evaluate the effect of a more severe depletion of vitamin C alone in a second experiment using gulonolactone oxidase mice carrying the hemizygous deletion of SVCT2 (the vitamin C transporter). METHODS AND RESULTS—After 8 weeks of a high-fat diet (16% lard and 0.2% cholesterol), atherosclerosis developed in the aortic sinus areas of mice in all diet groups. Each vitamin-deficient diet significantly decreased liver and brain contents of the corresponding vitamin. Combined deficiency of both vitamins increased lipid peroxidation, doubled plaque size, and increased plaque macrophage content by 2- to 3-fold in male mice, although only plaque macrophage content was increased in female mice. A more severe deficiency of vitamin C in gulonolactone oxidase mice with defective cellular uptake of vitamin C increased both oxidative stress and atherosclerosis in apolipoprotein E mice compared with littermates receiving a diet replete in vitamin C, again most clearly in males. CONCLUSION—Combined deficiencies of vitamins E and C are required to worsen early atherosclerosis in an apolipoprotein E–deficient mouse model. However, a more severe cellular deficiency of vitamin C alone promotes atherosclerosis when vitamin E is replete. To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative stress), 4 combinations of vitamin supplementation (low C/low E, low C/high E, high C/low E, and high C/high E) were studied in atherosclerosis-prone apolipoprotein E-deficient mice also unable to synthesize their own vitamin C (gulonolactone oxidase(-/-)); and to evaluate the effect of a more severe depletion of vitamin C alone in a second experiment using gulonolactone oxidase(-/-) mice carrying the hemizygous deletion of SVCT2 (the vitamin C transporter). After 8 weeks of a high-fat diet (16% lard and 0.2% cholesterol), atherosclerosis developed in the aortic sinus areas of mice in all diet groups. Each vitamin-deficient diet significantly decreased liver and brain contents of the corresponding vitamin. Combined deficiency of both vitamins increased lipid peroxidation, doubled plaque size, and increased plaque macrophage content by 2- to 3-fold in male mice, although only plaque macrophage content was increased in female mice. A more severe deficiency of vitamin C in gulonolactone oxidase(-/-) mice with defective cellular uptake of vitamin C increased both oxidative stress and atherosclerosis in apolipoprotein E(-/-) mice compared with littermates receiving a diet replete in vitamin C, again most clearly in males. Combined deficiencies of vitamins E and C are required to worsen early atherosclerosis in an apolipoprotein E-deficient mouse model. However, a more severe cellular deficiency of vitamin C alone promotes atherosclerosis when vitamin E is replete. |
Author | Shah, Sanket May, James M Fazio, Sergio Babaev, Vladimir R Linton, MacRae F Li, Liying |
AuthorAffiliation | From the Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn |
AuthorAffiliation_xml | – name: From the Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn |
Author_xml | – sequence: 1 givenname: Vladimir R surname: Babaev fullname: Babaev, Vladimir R organization: From the Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn – sequence: 2 givenname: Liying surname: Li fullname: Li, Liying – sequence: 3 givenname: Sanket surname: Shah fullname: Shah, Sanket – sequence: 4 givenname: Sergio surname: Fazio fullname: Fazio, Sergio – sequence: 5 givenname: MacRae F surname: Linton fullname: Linton, MacRae F – sequence: 6 givenname: James M surname: May fullname: May, James M |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23151150$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20558818$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kM9OGzEQxq0KVP60L9AD8gX1tDD2rvfPcRvSBgnEJaXHleMdKy5eO7U3Qrn1HXhDnqROE-DGZTyf9Ptmxt8JOXDeISFfGFwwVrLLdn7_rZ21ScAFh0YA_0COmeBFVpR5eZB6qJpMlAU_Iicx_gaAgnP4SI44CFHXrD4mbuKHhXHY03szysE4OqHSvakpvUJtlEGnNvSXDxFdpFMZ7Ia24xKDj8puq4k00e3KW7Pyq-BH3Jqf_z692Ed6axR-Ioda2oif9-8p-fl9Op_Mspu7H9eT9iZTRd3wTNaCQ18g5pXSveoVh0WdS62F7BEkl41SDVOlAsZzDahZ0-dVwwRgsWBVnp-Sr7u56ZQ_a4xjN5io0Frp0K9jV6U1KRcBieQ7UqVfxIC6WwUzyLDpGHTbmLt9zElAt4s5mc7249eLAftXy0uuCTjfAzIqaXWQTpn4xuVMMPZ_e7njHr0dMcQHu37E0C1R2nH53gX_AF2qmno |
CODEN | ATVBFA |
CitedBy_id | crossref_primary_10_1016_S1875_5364_22_60219_X crossref_primary_10_1152_physrev_00004_2012 crossref_primary_10_1159_000337593 crossref_primary_10_1089_jmf_2020_4852 crossref_primary_10_1016_j_freeradbiomed_2012_05_027 crossref_primary_10_1089_ars_2016_6963 crossref_primary_10_1080_08982104_2019_1630642 crossref_primary_10_1016_j_mam_2012_12_002 crossref_primary_10_1021_jf2046009 crossref_primary_10_1038_ncomms14977 crossref_primary_10_3390_nu6041752 crossref_primary_10_3390_cells9030584 crossref_primary_10_1016_j_freeradbiomed_2010_10_702 crossref_primary_10_1271_bbb_110059 crossref_primary_10_1007_s11883_018_0737_7 crossref_primary_10_1007_s40292_020_00416_8 crossref_primary_10_1007_s10517_013_1973_z crossref_primary_10_1017_S0007114521004384 crossref_primary_10_3390_diseases4030025 crossref_primary_10_3945_jn_112_168690 crossref_primary_10_1074_jbc_M115_654582 crossref_primary_10_1186_s40659_018_0183_6 |
Cites_doi | 10.1016/0531-5565(85)90009-9 10.1001/archinte.167.15.1610 10.1056/NEJM199901143400207 10.1111/j.1538-7836.2005.01370.x 10.1111/j.1365-3083.1987.tb02301.x 10.1016/j.cmet.2008.09.005 10.1161/01.cir.0000012142.69612.25 10.1016/0021-9150(87)90202-4 10.1073/pnas.94.9.4647 10.1016/j.pharmthera.2008.05.002 10.1001/jama.2008.600 10.1073/pnas.240462697 10.1016/0003-2697(86)90203-4 10.1016/S0076-6879(07)33006-1 10.1074/jbc.M002423200 10.1016/j.freeradbiomed.2006.05.013 10.1016/j.freeradbiomed.2007.06.019 10.1038/2685 10.1007/s11010-007-9650-z 10.1016/S0140-6736(02)09328-5 10.1073/pnas.97.2.841 10.1016/S0891-5849(97)00351-1 10.1038/0502-514 10.1161/01.cir.0000055186.40785.c4 10.1111/1523-1747.ep12286468 |
ContentType | Journal Article |
Copyright | 2010 American Heart Association, Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: 2010 American Heart Association, Inc. – notice: 2015 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1161/ATVBAHA.110.209502 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4636 |
EndPage | 1757 |
ExternalDocumentID | 10_1161_ATVBAHA_110_209502 20558818 23151150 10.1161/ATVBAHA.110.209502 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: DK020593 – fundername: NIGMS NIH HHS grantid: P50 GM015431 – fundername: NIDDK NIH HHS grantid: P30 DK020593 – fundername: NHLBI NIH HHS grantid: R01 HL086988-03 – fundername: NIDDK NIH HHS grantid: R01 DK050435 – fundername: NIGMS NIH HHS grantid: GM15431 – fundername: NIDDK NIH HHS grantid: DK050435 – fundername: NHLBI NIH HHS grantid: HL057986 – fundername: NIDDK NIH HHS grantid: R01 DK050435-15 – fundername: NHLBI NIH HHS grantid: R01 HL086988 |
GroupedDBID | - .Z2 01R 08R 0R 1J1 23N 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 55 5GY 5RE 5VS 71W 77Y 7O 7O~ AAAXR AAMOA AAMTA AAPBV AARTV AAXQO ABBUW ABXVJ ABZAD ACDDN ACEWG ACGFS ACGOD ACPRK ACWDW ACWRI ACXNZ ADACO ADBBV ADFPA ADNKB AE3 AENEX AFFNX AFUWQ AHMBA AHULI AHVBC AIJEX AJIOK AJNYG AJYGW ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII AWKKM BAWUL BOYCO C1A C45 CS3 DIK DUNZO E.X E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FL- FRP FW0 GJ GX1 H0 H0~ H13 HZ IKYAY IN IN~ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B LI0 N9A N~7 N~B N~M O0- O9- OAG OAH OB2 OCUKA ODA OHASI OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWW OWY OXXIT P-K P2P PQEST PQQKQ PZZ RAH RHF RIG RLZ RSW S4R S4S V2I WOQ WOW X3V X3W X7M Z2 ZA5 ZGI --- .3C .55 .GJ 0R~ AAGIX AAHPQ AAQKA AASOK AAUGY ABASU ABDIG ABQRW ACCJW ACILI ADGGA AE6 AEETU AFDTB AGINI AHJKT AHOMT AHRYX AJNWD AKALU AKULP ALMTX AMKUR AMNEI AOHHW AYCSE BS7 DIWNM EEVPB FCALG GNXGY GQDEL HZ~ IKREB IPNFZ IQODW OJAPA OWU OWV OWX OWZ T8P TEORI TR2 TSPGW VVN W3M W8F XXN XYM YFH ZZMQN AAAAV AAIQE AASCR ABJNI ABVCZ ACLDA ACXJB ADHPY AHQNM AINUH AJZMW BQLVK CGR CUY CVF ECM EIF ERAAH HLJTE NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4892-a8520d4ee37cfdcdc20b83aff5ade0a2a9cc91c6c0123f0ef19d379150e4b1733 |
ISSN | 1079-5642 |
IngestDate | Sat Oct 26 05:29:46 EDT 2024 Fri Aug 23 00:17:37 EDT 2024 Sat Nov 02 11:53:54 EDT 2024 Sun Oct 22 16:08:05 EDT 2023 Thu Aug 13 19:50:12 EDT 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | antioxidants Rodentia Nutrition disorder Cardiovascular disease Antioxidant genetically altered mice Vascular disease Vertebrata nutrition Mammalia Mouse Apolipoprotein E Animal Atherosclerosis |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4892-a8520d4ee37cfdcdc20b83aff5ade0a2a9cc91c6c0123f0ef19d379150e4b1733 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.110.209502 |
PMID | 20558818 |
PQID | 748964250 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_748964250 crossref_primary_10_1161_ATVBAHA_110_209502 pubmed_primary_20558818 pascalfrancis_primary_23151150 wolterskluwer_health_10_1161_ATVBAHA_110_209502 |
ProviderPackageCode | L-C C45 7O~ AARTV ADFPA OLH ASCII OLG AAMOA ODA ABZAD ABBUW JK3 ADNKB JK8 H0~ 1J1 OLV OLU JG8 OLW OLZ OLY F2K F2M F2L F2N OHASI AHVBC AJNYG FL- KMI K8S OVLEI AJIOK OPUJH V2I S4R S4S 4Q1 DUNZO OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI OB2 ACEWG .Z2 N~7 IKYAY OVIDH AWKKM 40H N~B OUVQU ORVUJ X3V X3W ACDDN ACWRI BOYCO AIJEX AAXQO AAMTA AAAXR E.X OWW OCUKA OWY 01R ACXNZ OL1 ABXVJ IN~ KD2 OXXIT 77Y ACWDW JF9 FW0 |
PublicationCentury | 2000 |
PublicationDate | 2010-September |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-September |
PublicationDecade | 2010 |
PublicationPlace | Philadelphia, PA |
PublicationPlace_xml | – name: Philadelphia, PA – name: United States |
PublicationTitle | Arteriosclerosis, thrombosis, and vascular biology |
PublicationTitleAlternate | Arterioscler Thromb Vasc Biol |
PublicationYear | 2010 |
Publisher | American Heart Association, Inc Lippincott Williams & Wilkins |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott Williams & Wilkins |
References | (e_1_3_3_6_2) 1957; 77 e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_18_2 e_1_3_3_13_2 e_1_3_3_12_2 e_1_3_3_15_2 e_1_3_3_14_2 e_1_3_3_10_2 (e_1_3_3_5_2) 1953; 69 (e_1_3_3_11_2) 1995; 62 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_1_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – ident: e_1_3_3_15_2 doi: 10.1016/0531-5565(85)90009-9 – ident: e_1_3_3_2_2 doi: 10.1001/archinte.167.15.1610 – ident: e_1_3_3_1_2 doi: 10.1056/NEJM199901143400207 – ident: e_1_3_3_10_2 doi: 10.1111/j.1538-7836.2005.01370.x – ident: e_1_3_3_24_2 doi: 10.1111/j.1365-3083.1987.tb02301.x – ident: e_1_3_3_25_2 doi: 10.1016/j.cmet.2008.09.005 – ident: e_1_3_3_8_2 doi: 10.1161/01.cir.0000012142.69612.25 – ident: e_1_3_3_23_2 doi: 10.1016/0021-9150(87)90202-4 – volume: 77 start-page: 106 year: 1957 ident: e_1_3_3_6_2 publication-title: Can Med Assoc J – ident: e_1_3_3_16_2 doi: 10.1073/pnas.94.9.4647 – ident: e_1_3_3_9_2 doi: 10.1016/j.pharmthera.2008.05.002 – ident: e_1_3_3_4_2 doi: 10.1001/jama.2008.600 – ident: e_1_3_3_12_2 doi: 10.1073/pnas.240462697 – ident: e_1_3_3_18_2 doi: 10.1016/0003-2697(86)90203-4 – ident: e_1_3_3_21_2 doi: 10.1016/S0076-6879(07)33006-1 – ident: e_1_3_3_22_2 doi: 10.1074/jbc.M002423200 – ident: e_1_3_3_13_2 doi: 10.1016/j.freeradbiomed.2006.05.013 – ident: e_1_3_3_28_2 doi: 10.1016/j.freeradbiomed.2007.06.019 – ident: e_1_3_3_26_2 doi: 10.1038/2685 – ident: e_1_3_3_20_2 doi: 10.1007/s11010-007-9650-z – ident: e_1_3_3_3_2 doi: 10.1016/S0140-6736(02)09328-5 – ident: e_1_3_3_7_2 doi: 10.1073/pnas.97.2.841 – ident: e_1_3_3_17_2 doi: 10.1016/S0891-5849(97)00351-1 – volume: 69 start-page: 17 year: 1953 ident: e_1_3_3_5_2 publication-title: Can Med Assoc J – ident: e_1_3_3_14_2 doi: 10.1038/0502-514 – ident: e_1_3_3_27_2 doi: 10.1161/01.cir.0000055186.40785.c4 – ident: e_1_3_3_19_2 doi: 10.1111/1523-1747.ep12286468 – volume: 62 start-page: 13322S year: 1995 ident: e_1_3_3_11_2 publication-title: Am J Clin Nutr |
SSID | ssj0004220 |
Score | 2.205615 |
Snippet | OBJECTIVE—To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with... To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with oxidative... Objective— To assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with... OBJECTIVETo assess the role of combined deficiencies of vitamins C and E on the earliest stages of atherosclerosis (an inflammatory condition associated with... |
SourceID | proquest crossref pubmed pascalfrancis wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1751 |
SubjectTerms | Animals Aortic Diseases - drug therapy Aortic Diseases - etiology Aortic Diseases - genetics Aortic Diseases - metabolism Aortic Diseases - pathology Apolipoproteins E - deficiency Apolipoproteins E - genetics Ascorbic Acid - metabolism Ascorbic Acid - pharmacology Ascorbic Acid Deficiency - complications Ascorbic Acid Deficiency - drug therapy Ascorbic Acid Deficiency - metabolism Atherosclerosis (general aspects, experimental research) Atherosclerosis - drug therapy Atherosclerosis - etiology Atherosclerosis - genetics Atherosclerosis - metabolism Atherosclerosis - pathology Biological and medical sciences Blood and lymphatic vessels Brain - metabolism Cardiology. Vascular system Dietary Supplements Disease Models, Animal Disease Progression Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female L-Gulonolactone Oxidase - deficiency L-Gulonolactone Oxidase - genetics Lipid Peroxidation Liver - metabolism Macrophages - metabolism Macrophages - pathology Male Medical sciences Mice Mice, Inbred C57BL Mice, Knockout Myocardium - metabolism Organic Anion Transporters, Sodium-Dependent - deficiency Organic Anion Transporters, Sodium-Dependent - genetics Orthopedic surgery Oxidative Stress Severity of Illness Index Sex Factors Sodium-Coupled Vitamin C Transporters Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Symporters - deficiency Symporters - genetics Time Factors Vitamin E - metabolism Vitamin E - pharmacology Vitamin E Deficiency - complications Vitamin E Deficiency - drug therapy Vitamin E Deficiency - metabolism Vitamins - metabolism Vitamins - pharmacology |
Title | Combined Vitamin C and Vitamin E Deficiency Worsens Early Atherosclerosis in Apolipoprotein E–Deficient Mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20558818 https://search.proquest.com/docview/748964250 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF5FRUJICHETjmofeKuc-j4e3SpVCi0IKQ2FF2svl6hJHOUAiX_JP2Jm12eJuF6s7MprO_7Gc-x-M0vI68iXXICrYKlYCst3fG5xiJatiPPcZ2DQfJ0kdv4uHF34by6Dy17vR4u1tN3wgfi-M6_kf1CFPsAVs2T_Adn6otABvwFfOALCcPwrjOFjhsAWXMYJRPhzzN_TawFVawjaBAtE6OzKj8VqDSHrgalonKLfV6zhenCcak5sivs1LAtduAEHW9XgDXLrO4yhFHmg02Y44oT7Lcx51cLHqEmuZaGnOvJPj9LhRBNsZ0xO59NVw1o8O_2E02dnzZbNo3RkZq4X102u9kn6-fS97larK8Mkq6YucNU96Uxd7ChBoacupjPkB7W0sh0lVhCaMlwDVWpq17ew2llblZdLPEZkk5ZeBifJadl4aEa77UeI9oNtvnL2hWGKxMAFH9R2G2tZMQRuGNGa2gj-cuDoWaRbLug-VLpvP7QK2LuuKZBR_qMqjyt0Dn-9a8dXursE1NgsN_ut7AqI4JxvBXIs1tc6xaLlKI3vk3tlhENTI64PSE8tHpLb5yWH4xGZVVJLSzmlxxTEpW4NaSO1tJRaqqWW3pBaCmd3pZa2pJai1D4mFyfD8fHIKvf8sIQfJ67F4sC1pa-UF4lcCilcm8cey_OASWUzlyVCJI4IBcYCua1yJ5FelMALVz53Is97QvYWxUI9I1TyJApCGScSnH7pcZYzj4GBdkXgKR7zPjmo3m62NKVdMh0Sh06WjidH6SiFhp0ZLPpkvwNAPaQCvE9ohUgGKhrX3dhCFdt1hgWeAGo85alBqhlsB0EMPnOfHHagy0wW9G-e5_mfnucFudN8cy_J3ma1Va_Agd7wfS2SPwFWTcc2 |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combined+Vitamin+C+and+Vitamin+E+Deficiency+Worsens+Early+Atherosclerosis+in+Apolipoprotein+E-Deficient+Mice&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=BABAEV%2C+Vladimir+R&rft.au=LIYING+LI&rft.au=SHAH%2C+Sanket&rft.au=FAZIO%2C+Sergio&rft.date=2010-09-01&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=1079-5642&rft.eissn=1524-4636&rft.volume=30&rft.issue=9&rft.spage=1751&rft.epage=1757&rft_id=info:doi/10.1161%2Fatvbaha.110.209502&rft.externalDBID=n%2Fa&rft.externalDocID=23151150 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon |